The Human Research Protection Program (HRPP) reviews and monitors research involving human subjects at UCSF and several affiliate institutions to ensure the ethical and equitable treatment of the research subjects. Read more about the HRPP program.
The HRPP is comprised of 3 groups:
- Institutional Review Board (IRB), which reviews human subject research studies — learn how to submit to the IRB.
- Quality Improvement Unit (QIU), which conducts monitoring, education and other QI activities.
- Human Gamete, Embryo and Stem Cell Research (GESCR) Committee.
IRB and COVID-19
Please read our FAQs, they will be continually updated in response to questions that arise.
- The IRB office, committee, and iRIS systems are fully operational.
- IRB Meetings are taking place remotely, on their normal schedule.
- We have established dedicated IRB analysts for COVID research. Our focus is to accelerate and facilitate COVID Research and to ensure all studies proceed per University policy.
News
- System (iRIS) Performance Issues Affecting Turnaround Times (5/11/22)
- IRB FAQs & Postponement of non-essential research uses of iohexol (5/10/22)
- Updated IRB Consent Form Templates: Implementation Deadline for New Studies is June 1, 2022 (5/4/22)
- iRIS System Performance Issues (4/21/22)
- iRIS System Upgrade: Details (4/18/22)
- Change in iRIS Functionality – “Copy Study” Disabled (2/22/22)
- Tissue Core Staffing Shortage (1/5/22)